Freeline Therapeutics Holdings Future Growth
Future criteria checks 0/6
Key information
57.2%
Earnings growth rate
66.8%
EPS growth rate
Biotechs earnings growth | 31.8% |
Revenue growth rate | 53.1% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 21 Feb 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 62 | 16 | 3 | 3 | 1 |
12/31/2025 | 31 | 13 | 0 | 0 | 1 |
12/31/2024 | N/A | -9 | -23 | -23 | 1 |
12/31/2023 | 1 | -48 | -66 | -65 | 1 |
9/30/2023 | 1 | -50 | -69 | -64 | N/A |
6/30/2023 | 1 | -53 | -77 | -71 | N/A |
3/31/2023 | N/A | -61 | -77 | -70 | N/A |
12/31/2022 | N/A | -89 | -85 | -78 | N/A |
9/30/2022 | N/A | -101 | -79 | -76 | N/A |
6/30/2022 | N/A | -117 | -86 | -83 | N/A |
3/31/2022 | N/A | -132 | -102 | -100 | N/A |
12/31/2021 | N/A | -140 | -112 | -108 | N/A |
9/30/2021 | N/A | -144 | -129 | -124 | N/A |
6/30/2021 | N/A | -138 | -136 | -132 | N/A |
3/31/2021 | N/A | -115 | -115 | -111 | N/A |
12/31/2020 | N/A | -96 | -97 | -95 | N/A |
9/30/2020 | N/A | -73 | -73 | -72 | N/A |
6/30/2020 | N/A | -63 | -53 | -51 | N/A |
3/31/2020 | N/A | -58 | -57 | -54 | N/A |
12/31/2019 | N/A | -54 | -55 | -52 | N/A |
12/31/2018 | N/A | -33 | -30 | -26 | N/A |
9/30/2017 | N/A | -17 | -20 | -19 | N/A |